Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alc-NHTSA: Marijuana and Alcohol Impairment on Simulated Driving
NCT04856566Phase 1Completed
- Sponsor
- Yale University
- Start
- Jul 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol and ethanol (4 arms), sponsored by Yale University. Primary endpoints: Cogstate 1-back/2-back task performance changes at 2.5 hours, Cogstate Social/Emotional Cognition Task performance changes at 2.5 hours and 14 more. Started Jul 2021; status: completed.
02
Drugs
dronabinolethanol
Beyond the preview
Go deeper on NCT04856566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04856566.